Skip to main content
Fig. 3 | Genome Medicine

Fig. 3

From: Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians

Fig. 3

Examples of differentially expressed lipids in T2D and associated metabolism pathways. A. DEMs in fatty acid metabolism pathways (free fatty acids: from upper left to lower left, palmitate, eicosapentaenoate (EPA;20:5n3), stearate, docohexaenoate (DHA;22:6n3), 3-hydroxybutyrate (BHBA); far right: fatty acid metabolism implicating FFA differentially expressed in this study. B. Examples of differentially expressed monoacylglycerols and diacylglycerols (products of lipolysis) in T2D. Monoacylglycerols: Left to right, 1-linoleoylglycerol (18:2); 2-linoleoylglycerol (18:2); 1-linoleoyglycerol (18:3). Diacylglycerols: Left to right, linoleoyl- linoleoyl-glycerol (18:2/18:2); oleoyl- oleoyl-glycerol (18:1/18:1); oleoyl-linoleoyl-glycerol (18:1/18:2)

Back to article page